▁Introduction 10.375
: 6.515625
<0x0A> 3.95703125
Chr 8.2578125
onic 2.064453125
▁infl 3.77734375
amm 0.332275390625
ation 0.0013294219970703125
▁is 1.2880859375
▁a 1.056640625
▁major 1.796875
▁concern 6.4375
▁in 0.75
▁individuals 6.54296875
▁with 0.403564453125
▁end 5.4140625
- 0.51513671875
stage 0.01207733154296875
▁ren 0.71337890625
al 0.00014269351959228516
▁disease 0.139892578125
▁( 0.626953125
ES 0.00628662109375
R 0.0007638931274414062
D 0.0007333755493164062
) 1.1708984375
▁under 5.109375
going 0.023193359375
▁d 1.3203125
ial 2.6941299438476562e-05
ysis 0.000560760498046875
. 0.80029296875
▁The 2.41796875
▁article 10.28125
▁" 3.1640625
Chr 1.74609375
onic 0.0010900497436523438
▁In 0.88525390625
fl 0.0032196044921875
amm 0.0511474609375
ation 0.0003256797790527344
▁in 1.15234375
▁End 1.6611328125
- 0.06024169921875
Stage 0.202392578125
▁Ren 0.0272674560546875
al 2.5272369384765625e-05
▁D 0.032745361328125
ise 0.0037136077880859375
ase 0.007083892822265625
▁and 3.05859375
▁D 2.10546875
ial 0.0224456787109375
ysis 0.00489044189453125
" 1.0185546875
▁del 6.484375
ves 0.5205078125
▁into 0.12017822265625
▁the 0.474365234375
▁leading 7.87890625
▁causes 1.21875
▁of 0.130126953125
▁chron 0.560546875
ic 0.0010766983032226562
▁infl 0.022857666015625
amm 0.0114288330078125
ation 0.00023555755615234375
▁in 0.77001953125
▁individuals 2.1015625
▁with 0.46435546875
▁E 0.2431640625
SR 0.00237274169921875
D 0.0005831718444824219
, 1.607421875
▁discuss 4.5703125
es 0.139892578125
▁the 0.7626953125
▁impact 3.900390625
▁of 0.328125
▁this 3.392578125
▁disease 4.2578125
▁on 0.658203125
▁clin 5.515625
ical 0.04833984375
▁out 0.65673828125
comes 0.0009288787841796875
, 0.370361328125
▁and 0.1424560546875
▁expl 3.2109375
ores 0.0007734298706054688
▁the 0.97509765625
▁role 2.265625
▁of 0.1688232421875
▁middle 13.3359375
▁mole 1.658203125
cules 0.4775390625
▁in 0.50927734375
▁the 1.6650390625
▁development 2.8125
▁of 0.15283203125
▁path 7.21875
ology 1.7265625
. 0.68212890625
▁Furthermore 4.80078125
, 0.00252532958984375
▁the 0.5185546875
▁article 0.51806640625
▁provides 3.1015625
▁ins 3.25390625
ights 0.0010318756103515625
▁into 0.2406005859375
▁the 0.56005859375
▁latest 4.4765625
▁break 4.5625
through 0.0016012191772460938
s 0.0941162109375
▁and 2.171875
▁research 3.18359375
▁in 1.8310546875
▁d 3.767578125
ial 0.024078369140625
ysis 0.00794219970703125
▁that 4.54296875
▁aim 3.947265625
▁to 0.08453369140625
▁stabil 7.23828125
ize 0.01457977294921875
▁this 4.1953125
▁condition 2.455078125
. 0.57568359375
▁This 4.3359375
▁ess 7.68359375
ay 0.0014896392822265625
▁will 2.572265625
▁analyze 3.89453125
▁the 0.452392578125
▁key 4.10546875
▁points 1.1494140625
▁presented 3.537109375
▁in 0.2069091796875
▁the 0.1588134765625
▁article 0.2113037109375
▁while 6.015625
▁offering 3.548828125
▁additional 3.05859375
▁pers 2.953125
pect 0.00012111663818359375
ives 1.5854835510253906e-05
▁on 1.5205078125
▁the 0.60693359375
▁topic 1.8505859375
. 0.398193359375
<0x0A> 0.21875
C 3.8203125
aus 0.66015625
es 0.016265869140625
▁of 0.09783935546875
▁Chron 0.1376953125
ic 0.00028061866760253906
▁In 0.01447296142578125
fl 0.0001289844512939453
amm 0.003620147705078125
ation 0.000194549560546875
▁in 0.33349609375
▁Ind 2.833984375
ividual 0.001007080078125
s 0.0017786026000976562
▁with 0.377197265625
▁E 0.83447265625
SR 0.0019588470458984375
D 0.0015592575073242188
: 3.744140625
<0x0A> 0.1075439453125
The 2.08984375
▁article 1.30859375
▁highlight 4.015625
s 0.0217132568359375
▁several 3.072265625
▁causes 1.7353515625
▁of 0.0853271484375
▁chron 0.07269287109375
ic 0.00012111663818359375
▁infl 0.0016603469848632812
amm 0.0011138916015625
ation 0.00011932849884033203
▁in 0.184814453125
▁E 2.69921875
SR 0.007450103759765625
D 0.00077056884765625
, 1.962890625
▁r 5.7265625
anging 0.0010852813720703125
▁from 0.004863739013671875
▁d 4.7578125
ial 0.81884765625
ysis 0.0293426513671875
- 1.037109375
related 0.77978515625
▁factors 2.421875
▁to 0.304931640625
▁com 5.171875
orb 0.0017671585083007812
id 0.0020160675048828125
ities 0.60888671875
. 0.80615234375
▁D 3.109375
ial 0.03814697265625
ysis 0.0025463104248046875
- 0.47119140625
related 0.05804443359375
▁factors 0.1708984375
▁such 2.818359375
▁as 0.0025424957275390625
▁memb 6.04296875
rane 0.057861328125
▁bio 7.73046875
in 7.859375
compat 1.44140625
ibility 0.044891357421875
, 0.6513671875
▁end 4.90625
ot 2.009765625
ox 0.0008993148803710938
in 1.435546875
▁expos 1.087890625
ure 0.00490570068359375
, 0.033233642578125
▁and 0.53662109375
▁ox 4.38671875
id 0.00594329833984375
ative 0.06414794921875
▁stress 0.091796875
▁contribute 3.091796875
▁to 0.088134765625
▁the 1.25390625
▁activation 5.640625
▁of 0.07757568359375
▁infl 1.6923828125
am 0.476318359375
mat 0.0002884864807128906
ory 1.537799835205078e-05
▁path 1.1650390625
ways 0.00505828857421875
. 0.86474609375
▁Additionally 2.962890625
, 0.0005555152893066406
▁com 2.876953125
orb 0.0011777877807617188
id 0.00060272216796875
ities 0.093505859375
▁like 3.177734375
▁hy 2.125
pert 0.00380706787109375
ension 0.0120697021484375
, 0.255859375
▁di 0.90576171875
ab 0.0004112720489501953
etes 0.0026111602783203125
, 0.25732421875
▁and 0.408935546875
▁long 9.3125
- 0.0841064453125
term 0.1279296875
▁in 4.55859375
fe 0.73974609375
ctions 7.271766662597656e-06
▁play 4.828125
▁a 0.235107421875
▁role 1.10546875
▁in 0.060455322265625
▁indu 3.5
cing 0.00021338462829589844
▁chron 0.32275390625
ic 0.0006031990051269531
▁infl 0.0096435546875
amm 0.016876220703125
ation 0.00030112266540527344
▁in 1.107421875
▁E 0.6640625
SR 0.002437591552734375
D 0.00041365623474121094
▁patients 0.6982421875
. 0.08709716796875
▁Under 5.82421875
standing 0.050323486328125
▁these 1.3271484375
▁causes 2.177734375
▁is 1.8671875
▁cru 1.810546875
cial 0.0002357959747314453
▁for 1.083984375
▁man 4.05859375
aging 0.0010824203491210938
▁and 2.26171875
▁developing 7.32421875
▁strateg 2.3359375
ies 0.002960205078125
▁to 0.2120361328125
▁prevent 1.1767578125
▁and 1.494140625
▁mit 3.80078125
ig 1.239776611328125e-05
ate 7.510185241699219e-05
▁chron 1.0615234375
ic 0.00022494792938232422
▁infl 0.0032901763916015625
amm 0.019073486328125
ation 0.0005488395690917969
▁in 0.476806640625
▁E 0.49267578125
SR 0.001316070556640625
D 0.0001971721649169922
. 1.5625
<0x0A> 0.18603515625
Imp 3.65625
act 0.00969696044921875
▁of 0.049072265625
▁Chron 0.062103271484375
ic 4.4345855712890625e-05
▁In 0.006549835205078125
fl 0.0001283884048461914
amm 0.002399444580078125
ation 2.7894973754882812e-05
▁on 0.7021484375
▁C 0.178955078125
lin 0.0006270408630371094
ical 0.0004506111145019531
▁Out 0.00839996337890625
comes 0.01471710205078125
: 0.1285400390625
<0x0A> 0.00286865234375
Chr 0.53564453125
onic 0.00026416778564453125
▁infl 0.003826141357421875
amm 0.0018367767333984375
ation 1.8477439880371094e-05
▁has 1.8828125
▁a 0.759765625
▁significant 0.9599609375
▁impact 0.1068115234375
▁on 0.0030670166015625
▁clin 0.3125
ical 0.0003085136413574219
▁out 0.010528564453125
comes 3.123283386230469e-05
▁in 0.2088623046875
▁individuals 0.7392578125
▁with 0.0494384765625
▁E 0.054046630859375
SR 0.0014257431030273438
D 5.1856040954589844e-05
. 0.342529296875
▁The 2.146484375
▁article 0.7939453125
▁emphas 5.7421875
izes 0.0097198486328125
▁that 0.8251953125
▁chron 0.69580078125
ic 0.001434326171875
▁infl 0.006847381591796875
amm 0.007099151611328125
ation 4.589557647705078e-05
▁serves 8.4375
▁as 0.050567626953125
▁an 2.025390625
▁independent 1.5185546875
▁risk 0.6328125
▁factor 0.0166168212890625
▁for 0.0352783203125
▁card 1.7978515625
i 0.0245208740234375
ov 0.0009632110595703125
asc 4.9591064453125e-05
ular 2.6226043701171875e-06
▁dise 3.5078125
ases 0.0005125999450683594
, 0.88671875
▁mort 3.29296875
ality 0.0004930496215820312
, 0.0259552001953125
▁and 0.120361328125
▁hospital 1.580078125
ization 0.6015625
. 0.8037109375
▁It 2.326171875
▁cont 5.06640625
ributes 0.00913238525390625
▁to 0.0552978515625
▁the 0.591796875
▁path 5.640625
ogen 0.6474609375
esis 0.00395965576171875
▁of 0.0265960693359375
▁a 2.646484375
ther 0.10809326171875
os 0.00940704345703125
cl 0.09454345703125
eros 0.00010979175567626953
is 4.410743713378906e-06
, 0.4423828125
▁ar 3.15625
ter 0.0694580078125
ial 0.75390625
▁st 1.2392578125
iff 0.13232421875
ness 0.429443359375
, 0.00838470458984375
▁and 0.389404296875
▁acceler 6.58984375
ated 0.01091766357421875
▁card 3.095703125
i 0.70947265625
ov 0.0100860595703125
asc 5.7578086853027344e-05
ular 5.960464477539062e-07
▁events 4.14453125
. 0.387939453125
▁Moreover 2.837890625
, 0.00012350082397460938
▁chron 0.457275390625
ic 0.0004475116729736328
▁infl 0.004364013671875
amm 0.004180908203125
ation 4.38690185546875e-05
▁dis 6.95703125
rupt 0.080078125
s 0.0002963542938232422
▁the 0.701171875
▁balance 4.43359375
▁of 0.431640625
▁imm 1.5625
une 0.14990234375
▁responses 1.880859375
▁and 0.9033203125
▁ex 4.21484375
ac 0.312255859375
erb 0.00042438507080078125
ates 0.0052032470703125
▁kid 6.90234375
ney 0.00196075439453125
▁damage 1.3076171875
. 0.50732421875
▁These 3.806640625
▁out 3.3671875
comes 0.0006604194641113281
▁highlight 3.5546875
▁the 0.061920166015625
▁ur 3.193359375
gent 0.14013671875
▁need 0.01013946533203125
▁for 0.48291015625
▁inter 4.171875
vent 0.32958984375
ions 0.0138702392578125
▁target 3.416015625
ing 0.09185791015625
▁chron 0.490966796875
ic 0.0004017353057861328
▁infl 0.0021877288818359375
amm 0.005523681640625
ation 5.996227264404297e-05
▁in 0.7919921875
▁E 0.54345703125
SR 0.0006546974182128906
D 0.00014150142669677734
▁patients 0.59228515625
▁to 2.826171875
▁improve 0.65966796875
▁their 1.572265625
▁clin 0.64208984375
ical 0.0007653236389160156
▁pro 5.625
gn 0.06719970703125
osis 0.04156494140625
. 0.3212890625
<0x0A> 0.0518798828125
Role 1.099609375
▁of 0.003208160400390625
▁Middle 0.01557159423828125
▁M 0.06817626953125
ole 0.01690673828125
cules 0.007038116455078125
▁in 0.034637451171875
▁Path 5.8359375
ology 0.68505859375
: 0.303955078125
<0x0A> 0.0028667449951171875
Middle 2.08984375
▁mole 0.0135955810546875
cules 0.007457733154296875
▁play 1.4560546875
▁a 0.352294921875
▁cru 1.486328125
cial 0.00012433528900146484
▁role 0.0019178390502929688
▁in 0.001007080078125
▁the 0.578125
▁development 0.408447265625
▁of 0.1588134765625
▁path 0.7578125
ology 0.0748291015625
▁associated 4.08984375
▁with 0.005458831787109375
▁E 1.5556640625
SR 0.001934051513671875
D 0.00030303001403808594
▁and 3.373046875
▁chron 3.8984375
ic 0.0007271766662597656
▁infl 0.0053253173828125
amm 0.00208282470703125
ation 8.940696716308594e-05
. 0.0892333984375
▁As 4.99609375
▁the 2.259765625
▁article 1.9287109375
▁suggests 3.9375
, 0.01026153564453125
▁middle 1.76171875
▁mole 0.00807952880859375
cules 0.00908660888671875
, 3.541015625
▁including 1.5859375
▁ 6.73828125
β 1.591796875
2 1.111328125
- 0.306884765625
m 0.54931640625
icro 0.002269744873046875
glob 0.00133514404296875
ul 0.005237579345703125
in 0.004154205322265625
, 0.63623046875
▁par 6.953125
ath 0.205322265625
y 0.00969696044921875
roid 0.0042724609375
▁h 0.01288604736328125
orm 9.5367431640625e-06
one 0.008087158203125
▁fragments 12.6875
, 0.09429931640625
▁and 0.55517578125
▁advanced 7.2890625
▁g 0.0287628173828125
ly 0.002063751220703125
cation 0.0293426513671875
▁end 0.01522064208984375
▁products 0.462158203125
, 0.1612548828125
▁accum 4.66015625
ulate 0.0044708251953125
▁due 4.3125
▁to 0.0003314018249511719
▁decre 6.53515625
ased 0.041015625
▁ren 1.6689453125
al 0.007137298583984375
▁clear 1.578125
ance 0.007152557373046875
▁in 2.88671875
▁E 0.8330078125
SR 0.0017108917236328125
D 0.0005078315734863281
▁patients 0.267333984375
. 0.16796875
▁These 1.36328125
▁mole 0.303466796875
cules 0.003559112548828125
, 3.099609375
▁especially 5.69921875
▁ 0.5224609375
β 0.0023517608642578125
2 0.01308441162109375
- 0.015899658203125
m 0.0013446807861328125
icro 0.0012226104736328125
glob 0.0022125244140625
ul 0.00031638145446777344
in 0.0024471282958984375
, 0.1873779296875
▁have 2.67578125
▁pro 4.07421875
- 0.6982421875
infl 0.043731689453125
am 0.0010356903076171875
mat 7.343292236328125e-05
ory 2.5391578674316406e-05
▁properties 0.66748046875
▁and 0.65234375
▁contribute 1.5830078125
▁to 0.01727294921875
▁the 0.376220703125
▁activation 2.96484375
▁of 0.047576904296875
▁infl 2.115234375
am 0.120849609375
mat 7.30752944946289e-05
ory 6.4373016357421875e-06
▁path 0.349365234375
ways 0.0010013580322265625
, 2.25
▁eventually 7.4609375
▁leading 0.279052734375
▁to 0.00015366077423095703
▁t 3.79296875
issue 0.0031452178955078125
▁damage 0.36767578125
▁and 0.64208984375
▁system 4.2578125
ic 0.00875091552734375
▁infl 0.75927734375
amm 0.0809326171875
ation 0.00037026405334472656
. 0.0771484375
▁The 2.06640625
▁identification 6.984375
▁and 1.322265625
▁target 2.44921875
ing 0.11907958984375
▁of 0.005809783935546875
▁middle 1.6455078125
▁mole 0.002773284912109375
cules 0.005825042724609375
▁hold 4.76953125
▁promise 0.92236328125
▁as 2.48828125
▁an 2.376953125
▁effective 0.66259765625
▁approach 2.337890625
▁to 0.33251953125
▁reducing 3.044921875
▁chron 1.5283203125
ic 0.00012767314910888672
▁infl 0.0019855499267578125
amm 0.0050201416015625
ation 0.0001348257064819336
▁in 0.61865234375
▁E 0.1483154296875
SR 0.00044727325439453125
D 0.00015079975128173828
▁patients 0.376708984375
. 0.2340087890625
<0x0A> 0.076171875
Lat 3.408203125
est 0.017730712890625
▁Break 1.0458984375
through 0.0008840560913085938
s 0.032318115234375
▁and 0.92529296875
▁Research 0.08544921875
▁in 0.30615234375
▁D 0.04449462890625
ial 0.0001304149627685547
ysis 0.0003726482391357422
: 0.163330078125
<0x0A> 0.0035839080810546875
Rec 4.2578125
ent 0.30322265625
▁adv 0.7119140625
anc 0.73486328125
ements 6.198883056640625e-06
▁in 0.1400146484375
▁d 0.404052734375
ial 3.266334533691406e-05
ysis 0.0010843276977539062
▁aim 5.203125
▁to 0.00872802734375
▁stabil 1.12890625
ize 0.0022068023681640625
▁the 1.4140625
▁condition 1.212890625
▁of 0.2197265625
▁individuals 1.1171875
▁with 0.07135009765625
▁E 0.12237548828125
SR 0.0005726814270019531
D 0.00013256072998046875
▁and 1.3193359375
▁mit 3.625
ig 5.7220458984375e-06
ate 0.0010366439819335938
▁chron 0.8037109375
ic 8.0108642578125e-05
▁infl 0.0011911392211914062
amm 0.003986358642578125
ation 0.00010991096496582031
. 0.2071533203125
▁The 1.4697265625
▁article 0.20556640625
▁mentions 5.1015625
▁emer 6.078125
ging 0.004032135009765625
▁d 4.0859375
ial 0.0027904510498046875
ysis 0.043182373046875
▁techniques 2.35546875
, 1.0546875
▁such 0.498046875
▁as 0.00031304359436035156
▁online 8.78125
▁hem 2.26953125
odia 2.96875
fil 0.0008649826049804688
tr 0.00036907196044921875
ation 0.00023758411407470703
▁( 0.8818359375
H 4.41796875
DF 0.022064208984375
) 0.82177734375
▁and 0.12225341796875
▁high 4.73828125
▁cut 11.7265625
- 1.4033203125
off 0.016754150390625
▁( 3.775390625
H 1.1162109375
CO 0.05401611328125
) 0.1666259765625
▁memb 3.228515625
ran 0.81884765625
es 0.002124786376953125
, 0.297607421875
▁which 1.150390625
▁have 2.103515625
▁shown 1.916015625
▁prom 0.9697265625
ising 3.635883331298828e-05
▁results 0.19775390625
▁in 0.1617431640625
▁reducing 0.9248046875
▁infl 2.6796875
amm 0.260009765625
ation 0.0005159378051757812
▁and 0.93798828125
▁impro 1.10546875
ving 2.5510787963867188e-05
▁patient 2.326171875
▁out 0.1756591796875
comes 0.0006537437438964844
. 0.03411865234375
▁The 2.466796875
▁combination 6.21484375
▁of 0.00787353515625
▁these 1.0126953125
▁advanced 5.1328125
▁techniques 1.2890625
▁with 0.455322265625
▁optimized 4.59765625
▁d 1.765625
ial 0.0006036758422851562
ys 3.162109375
ate 0.1373291015625
▁composition 0.80908203125
▁and 0.73974609375
▁individual 5.84765625
ized 0.1636962890625
▁treatment 1.6142578125
▁plans 1.755859375
▁further 4.5390625
▁enh 1.97265625
ances 0.428955078125
▁their 3.43359375
▁effect 1.57421875
iveness 0.00514984130859375
. 0.284423828125
▁Furthermore 2.69921875
, 0.0002422332763671875
▁research 2.466796875
ers 0.80419921875
▁are 0.2291259765625
▁investig 2.541015625
ating 1.7523765563964844e-05
▁novel 2.173828125
▁th 1.7666015625
era 0.00020766258239746094
pe 1.0967254638671875e-05
ut 6.9141387939453125e-06
ic 0.2017822265625
▁targets 1.6279296875
, 1.251953125
▁including 1.6162109375
▁cy 3.625
tok 0.0276641845703125
ines 0.43994140625
▁and 0.7548828125
▁infl 3.60546875
am 0.53125
mat 0.0001995563507080078
ory 0.00013780593872070312
▁signal 2.21484375
ing 0.0751953125
▁path 0.2225341796875
ways 0.0033588409423828125
, 0.052734375
▁to 0.92041015625
▁develop 1.2216796875
▁anti 5.359375
- 0.0195770263671875
infl 0.0084075927734375
am 0.024444580078125
mat 0.00025153160095214844
ory 2.09808349609375e-05
▁dru 1.0576171875
gs 6.556510925292969e-06
▁specific 7.43359375
▁to 0.37451171875
▁E 1.1025390625
SR 0.0015840530395507812
D 0.0003311634063720703
▁patients 0.403076171875
. 0.1390380859375
<0x0A> 1.1796875
Con 2.21875
clusion 0.2159423828125
: 0.2783203125
<0x0A> 5.1953125
In 2.568359375
▁conclusion 0.6201171875
, 0.0023021697998046875
▁chron 1.267578125
ic 0.00055694580078125
▁infl 0.0023059844970703125
amm 0.0020275115966796875
ation 5.9485435485839844e-05
▁is 0.5859375
▁a 0.1378173828125
▁complex 4.63671875
▁issue 2.455078125
▁in 2.61328125
▁E 2.244140625
SR 0.0009150505065917969
D 0.0001957416534423828
▁patients 0.53173828125
▁under 2.525390625
going 0.004978179931640625
▁d 0.06610107421875
ial 1.9073486328125e-06
ysis 0.0002014636993408203
. 0.2115478515625
▁Under 3.248046875
standing 0.0133209228515625
▁the 0.39404296875
▁leading 3.373046875
▁causes 0.0361328125
▁of 0.356201171875
▁chron 0.2362060546875
ic 0.0002880096435546875
▁infl 0.0003535747528076172
amm 0.0006804466247558594
ation 4.470348358154297e-05
, 1.669921875
▁its 1.68359375
▁impact 0.175537109375
▁on 0.0134429931640625
▁clin 0.041290283203125
ical 0.00013577938079833984
▁out 0.01436614990234375
comes 2.777576446533203e-05
, 0.02374267578125
▁and 0.032012939453125
▁the 0.426025390625
▁role 0.4130859375
▁of 0.01457977294921875
▁middle 0.0625
▁mole 0.0045928955078125
cules 0.0009226799011230469
▁in 0.134033203125
▁the 0.333740234375
▁development 0.11309814453125
▁of 0.00310516357421875
▁path 0.058349609375
ology 0.007228851318359375
▁is 0.982421875
▁vital 3.287109375
▁for 0.31005859375
▁effective 4.51953125
▁management 0.7412109375
▁and 0.53759765625
▁prevent 1.57421875
ion 0.0236663818359375
. 1.49609375
▁Fort 8.515625
un 0.0242919921875
ately 0.00016570091247558594
, 0.0005388259887695312
▁recent 0.64404296875
▁break 1.568359375
through 7.796287536621094e-05
s 0.00392913818359375
▁and 0.29345703125
▁on 4.97265625
going 0.003997802734375
▁research 0.01751708984375
▁in 0.97021484375
▁d 0.035552978515625
ial 4.172325134277344e-06
ysis 0.00022232532501220703
▁offer 2.6328125
▁hope 1.4501953125
▁for 0.19677734375
▁stabil 4.546875
izing 0.0997314453125
▁the 1.6552734375
▁condition 0.16259765625
▁and 2.69921875
▁alle 5.234375
vi 0.0016183853149414062
ating 0.00032782554626464844
▁chron 0.8603515625
ic 4.8041343688964844e-05
▁infl 0.0030078887939453125
amm 0.004566192626953125
ation 0.00010085105895996094
▁through 6.46484375
▁advanced 3.8671875
▁techniques 1.6181640625
▁and 0.6240234375
▁target 1.5810546875
ed 0.0260009765625
▁ther 0.6044921875
ap 0.10650634765625
ies 3.2186508178710938e-06
. 0.0262298583984375
▁By 4.05859375
▁address 3.361328125
ing 3.635883331298828e-05
▁chron 2.2109375
ic 0.00012612342834472656
▁infl 0.0010461807250976562
amm 0.0021305084228515625
ation 0.00012624263763427734
▁in 1.19140625
▁E 0.2138671875
SR 0.0003216266632080078
D 0.00023305416107177734
▁patients 0.279541015625
, 0.1885986328125
▁health 3.7578125
care 0.1495361328125
▁profession 1.208984375
als 8.344650268554688e-07
▁can 0.299072265625
▁significantly 4.1953125
▁improve 0.2064208984375
▁the 1.7236328125
▁quality 0.8828125
▁of 0.016204833984375
▁life 0.038177490234375
▁and 0.7626953125
▁pro 3.2890625
gn 0.006069183349609375
osis 0.004192352294921875
▁for 0.9052734375
▁these 0.9189453125
▁individuals 0.42626953125
. 0.050384521484375
